NHRI researchers make key lung cancer finding

A STEP FORWARD: The team found that inhibiting the succinate levels in mice increased their survival rate and that succinate levels could be used as a biomarker

Taipei Times
Date: Jan 21, 2020
By: Lee I-chia  /  Staff reporter

The National Health Research Institutes (NHRI) yesterday said it had discovered that succinate

From left, Tri-Service General Hospital physicians Hsu Yu-Juei and Huang Tsai-wang, National Health Research Institutes (NHRI) Secretary-General Wu Shiow-ing, NHRI Institute of Cellular and System Medicine director Lin Hsiu-fang and associate researcher Kuo Cheng-chin, and research team member Wu Jing-yiing give the thumbs up at a news conference at the Ministry of Health and Welfare in Taipei yesterday.
Photo: Wu Liang-yi, Taipei Times

levels in blood serum could serve as a potential biomarker for lung cancer progression, and that inhibiting succinate levels might reduce the risk of lung cancer metastasis.

NHRI Institute of Cellular and System Medicine associate researcher Kuo Cheng-chin (郭呈欽) said that cancer has been the most common cause of death in Taiwan for many years.

Among them, non-small cell lung cancer has a relatively poor prognosis, he said.

As there is no effective screening method for non-small cell lung cancer, patients are usually diagnosed in the later stages, he added.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.